New Delhi, Sep 18 (IANS) To support cutting-edge research and development in the field of biotechnology, the Union Cabinet on Wednesday approved the continuation of the two umbrella schemes of Department of Biotechnology (DBT) as one unified scheme.
Called ‘Biotechnology Research Innovation and Entrepreneurship Development (Bio-RIDE), the proposed outlay for the implementation of the unified scheme is Rs 9,197 crore during the 15th finance Commission period from 2021-22 to 2025-26.
The scheme has three broad components: biotechnology research and development (R&D), industrial and entrepreneurship development (I&ED) and biomanufacturing and biofoundry.
It will nurture a thriving ecosystem for startups by providing seed funding, incubation support, and mentorship to bio-entrepreneurs.
The scheme will offer grants and incentives for cutting-edge research and development in areas like synthetic biology, biopharmaceuticals, bioenergy, and bioplastics.
“Bio-RIDE will create synergies between academic institutions, research organisations, and industry to accelerate the commercialization of bio-based products and technologies,” said the ministry.
The scheme is designed to foster innovation, promote bio-entrepreneurship, and strengthen India’s position as a global leader in biomanufacturing and biotechnology.
A significant focus will be placed on promoting environmentally sustainable practices in biomanufacturing, aligned with India’s green goals, the ministry noted.
To enable circular-bioeconomy in the country, a component on biomanufacturing and biofoundry is being initiated in alignment with ‘Lifestyle for the Environment (LiFE)’ launched by Prime Minister Narendra Modi to propel mitigation of global climate change by incorporating green and friendly environmental solutions in every aspect of life.
According to the ministry, the new component aspires to nurture the immense potential of ‘biomanufacturing’ to facilitate development of indigenous innovative solutions to improve healthcare outcomes, enhance agriculture productivity, foster growth of the bioeconomy and scale-up and commercialisation of bio-based products.
Biomanufacturing and bio-foundry are part of the new BioE3 (Biotechnology for Economy, Environment and Employment) policy that will drive India’s green growth.
The country’s bioeconomy rose from $10 billion in 2014 to over $130 billion in 2024. It is projected to reach $300 billion by 2030.
–IANS
na/
Disclaimer
The information contained in this website is for general information purposes only. The information is provided by TodayIndia.news and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.
Through this website you are able to link to other websites which are not under the control of TodayIndia.news We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, TodayIndia.news takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
For any legal details or query please visit original source link given with news or click on Go to Source.
Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.
If you are not willing to accept this disclaimer then we recommend reading news post in its original language.
